Announcements Trials
Browse Landscape

Status

Completed 50Unknown 29Recruiting 26Not yet recruiting 7Active not recruiting 7Withdrawn 4Terminated 4Enrolling by invitation 3

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 15Observational 4

Sponsor

Cancer Type

NET 4Endocrine 4Gastrointestinal 1

Conditions

Neoplasms 69Breast Neoplasms 68Prostatic Neoplasms 48Lung Neoplasms 34Carcinoma, Non-Small-Cell Lung 26Colorectal Neoplasms 19Pancreatic Neoplasms 17Carcinoma, Hepatocellular 16Brain Neoplasms 15Leukemia, Myeloid, Acute 14Lymphoma 13Colonic Neoplasms 13Carcinoma, Renal Cell 13Melanoma 12Head and Neck Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Ovarian Neoplasms 11Neoplasm Metastasis 10Lymphoma, Non-Hodgkin 10Leukemia, Lymphocytic, Chronic, B-Cell 10Hematologic Neoplasms 10Uterine Cervical Neoplasms 9Liver Neoplasms 9Multiple Myeloma 8Leukemia 8Glioblastoma 8Stomach Neoplasms 7Recurrence 7Papillomavirus Infections 7Hodgkin Disease 7

Interventions

telotristat ethyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Observational × Neuroendocrine Tumors × Clear all
NCT04432532 2025-02-10

NETAT

University of Pennsylvania

Withdrawn
EndocrineNET

Adrenal Gland Neoplasms, Neuroendocrine Tumors

NCT00657332 2023-11-28

Clinical and Pathologic Studies in Neuroendocrine Tumors

Stanford University

Withdrawn
EndocrineNET

Carcinoid Tumor, Neuroendocrine Tumors

NCT04034745 2020-12-30

Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/Gain

Cedars-Sinai Medical Center

Withdrawn
EndocrineGastrointestinalNET

Cachexia, Neoplasms, Pancreatic Neoplasms, Neuroendocrine Tumors

NCT03895463 2020-11-05

NETways

Ipsen

Withdrawn
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡